The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence

The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence Eur J Nucl Med Mol Imaging (2017) 44:1712–1720 DOI 10.1007/s00259-017-3698-0 ORIGINAL ARTICLE The role of F-FDG PET/CT in the detection of osteosarcoma recurrence 1 2 2 2 Andrea Angelini & Francesco Ceci & Paolo Castellucci & Tiziano Graziani & 2 1 3 3 Giulia Polverari & Giulia Trovarelli & Emanuela Palmerini & Stefano Ferrari & 2 1 Stefano Fanti & Pietro Ruggieri Received: 12 January 2017 /Accepted: 28 March 2017 /Published online: 12 April 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract in 2.7% (1/37) case; multiple sites of uptake in 32.4% (12/37). Aim The aim of this study was to investigate the diagnostic Histology resulted positive in 92% (34/37) of patients. A total accuracy of F-FDG-PET/CT in osteosarcoma patients sus- of 51 pathologic lesions were evaluated (22 local relapse, 11 picious for disease recurrence after adequate surgical therapy. lung metastasis, 10 metastatic LNs, eight distant metastatic Methods Inclusion criteria were: a) adequate surgical treatment lesions). On a per-patient analysis F-FDG-PET/CT showed for proven osteosarcoma and documented complete remission a sensitivity, specificity, accuracy, PPV, and NPV of 91%, after therapy; b) F-FDG-PET/CT performed during follow- 75%, 89%, 97%, 50%. On a per-site analysis the performance up for clinical/diagnostic suspicion of relapse; http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Nuclear Medicine and Molecular Imaging Springer Journals

Loading next page...
 
/lp/springer_journal/the-role-of-18f-fdg-pet-ct-in-the-detection-of-osteosarcoma-recurrence-fi0cMgKCTI
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1619-7070
eISSN
1619-7089
D.O.I.
10.1007/s00259-017-3698-0
Publisher site
See Article on Publisher Site

Abstract

Eur J Nucl Med Mol Imaging (2017) 44:1712–1720 DOI 10.1007/s00259-017-3698-0 ORIGINAL ARTICLE The role of F-FDG PET/CT in the detection of osteosarcoma recurrence 1 2 2 2 Andrea Angelini & Francesco Ceci & Paolo Castellucci & Tiziano Graziani & 2 1 3 3 Giulia Polverari & Giulia Trovarelli & Emanuela Palmerini & Stefano Ferrari & 2 1 Stefano Fanti & Pietro Ruggieri Received: 12 January 2017 /Accepted: 28 March 2017 /Published online: 12 April 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract in 2.7% (1/37) case; multiple sites of uptake in 32.4% (12/37). Aim The aim of this study was to investigate the diagnostic Histology resulted positive in 92% (34/37) of patients. A total accuracy of F-FDG-PET/CT in osteosarcoma patients sus- of 51 pathologic lesions were evaluated (22 local relapse, 11 picious for disease recurrence after adequate surgical therapy. lung metastasis, 10 metastatic LNs, eight distant metastatic Methods Inclusion criteria were: a) adequate surgical treatment lesions). On a per-patient analysis F-FDG-PET/CT showed for proven osteosarcoma and documented complete remission a sensitivity, specificity, accuracy, PPV, and NPV of 91%, after therapy; b) F-FDG-PET/CT performed during follow- 75%, 89%, 97%, 50%. On a per-site analysis the performance up for clinical/diagnostic suspicion of relapse;

Journal

European Journal of Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Apr 12, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off